Norway· NO-ID_F0B0F17F-6C11-4757-BBE9-7D6E7B7C9CB1

Zolinza

A vorinostat product containing vorinostat, registered in Norway by Merck. The same ATC class is registered in 2 of our 19 countries.

ATC L01XH01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedZolinzaATCL01XH01REGISTER NO.NO-ID_F0B0F17F-6C11-4…PACKS LISTED2CHECKEDSeptember 25, 2026

Where it is registered

Vorinostat is registered in 2 of 19 countries.

Countries holding a registration under ATC L01XH01 (vorinostat), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 1 of them publish a price we can compare per daily dose

Vorinostat · ATC L01XH01

2 / 19 countries

  • Canada
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Vorinostat
Manufacturer
Merck
Country
Norway (NO)
ATC code
L01XH01
ATC class
Vorinostat
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_F0B0F17F-6C11-4757-BBE9-7D6E7B7C9CB1
  • no_varenummer
    364370
    120

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

63 interactions on record for vorinostat.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Vorinostat · interactions on record

63 records

  • 2 severe
  • 61 moderate

Most severe, free to view

  • ThalidomideL04AX02severe
  • Valproic acidN03AG01severe
  • LiraglutidA08AX02moderate
  • SemaglutidA08AX03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vorinostat in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vorinostat products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d5e448c5-95d7-4bf1-9bb4-f7be09ca2ada
GET /v1/drugs/d5e448c5-95d7-4bf1-9bb4-f7be09ca2ada?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsel, hard",
  "source": "fest",
  "status": "A",
  "atc_name": "Vorinostat",
  "merkevare_id": "ID_F0B0F17F-6C11-4757-BBE9-7D6E7B7C9CB1",
  "name_form_strength": "Zolinza kaps 100 mg",
  "prescription_group": "C"
}

See everything about vorinostat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.